Chronic Kidney Disease (Chronic Renal Failure) - Pipeline Review, H2 2016

Date: October 19, 2016
Pages: 197
Price:
US$ 2,000.00
License [?]:
Publisher: Global Markets Direct
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: CBC99D7D3A1EN
Leaflet:

Download PDF Leaflet

Chronic Kidney Disease (Chronic Renal Failure) - Pipeline Review, H2 2016
Chronic Kidney Disease (Chronic Renal Failure) - Pipeline Review, H2 2016

Summary

Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Chronic Kidney Disease (Chronic Renal Failure) - Pipeline Review, H2 2016, provides an overview of the Chronic Kidney Disease (Chronic Renal Failure) (Genito Urinary System And Sex Hormones) pipeline landscape.

Chronic kidney disease is the slow loss of kidney function over time. Signs and symptoms of kidney disease include nausea, vomiting, loss of appetite, fatigue and weakness, sleep problems, hiccups and swelling of feet and ankles. The predisposing factors include age, diabetes, high blood pressure, heart disease, smoking, obesity and high cholesterol.

Report Highlights

Global Markets Direct's Pharmaceutical and Healthcare latest pipeline guide Chronic Kidney Disease (Chronic Renal Failure) - Pipeline Review, H2 2016, provides comprehensive information on the therapeutics under development for Chronic Kidney Disease (Chronic Renal Failure) (Genito Urinary System And Sex Hormones), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

The Chronic Kidney Disease (Chronic Renal Failure) (Genito Urinary System And Sex Hormones) pipeline guide also reviews of key players involved in therapeutic development for Chronic Kidney Disease (Chronic Renal Failure) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Filing rejected/Withdrawn, Phase III, Phase II, Phase I, Preclinical and Discovery stages are 1, 1, 9, 15, 19 and 7 respectively for Similarly, the Universities portfolio in Phase I stages comprises 1 molecules, respectively for Chronic Kidney Disease (Chronic Renal Failure).

Chronic Kidney Disease (Chronic Renal Failure) (Genito Urinary System And Sex Hormones) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Global Markets Direct’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

Note: Certain content / sections in the pipeline guide may be removed or altered based on the availability and relevance of data.

Scope
  • The pipeline guide provides a snapshot of the global therapeutic landscape of Chronic Kidney Disease (Chronic Renal Failure) (Genito Urinary System And Sex Hormones).
  • The pipeline guide reviews pipeline therapeutics for Chronic Kidney Disease (Chronic Renal Failure) (Genito Urinary System And Sex Hormones) by companies and universities/research institutes based on information derived from company and industry-specific sources.
  • The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
  • The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
  • The pipeline guide reviews key companies involved in Chronic Kidney Disease (Chronic Renal Failure) (Genito Urinary System And Sex Hormones) therapeutics and enlists all their major and minor projects.
  • The pipeline guide evaluates Chronic Kidney Disease (Chronic Renal Failure) (Genito Urinary System And Sex Hormones) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
  • The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
  • The pipeline guide reviews latest news related to pipeline therapeutics for Chronic Kidney Disease (Chronic Renal Failure) (Genito Urinary System And Sex Hormones)
Reasons to buy
  • Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
  • Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
  • Find and recognize significant and varied types of therapeutics under development for Chronic Kidney Disease (Chronic Renal Failure) (Genito Urinary System And Sex Hormones).
  • Classify potential new clients or partners in the target demographic.
  • Develop tactical initiatives by understanding the focus areas of leading companies.
  • Plan mergers and acquisitions meritoriously by identifying key players and it’s most promising pipeline therapeutics.
  • Formulate corrective measures for pipeline projects by understanding Chronic Kidney Disease (Chronic Renal Failure) (Genito Urinary System And Sex Hormones) pipeline depth and focus of Indication therapeutics.
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and Scope.
  • Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.
Introduction
Global Markets Direct Report Coverage
Chronic Kidney Disease (Chronic Renal Failure) Overview
Therapeutics Development
Pipeline Products for Chronic Kidney Disease (Chronic Renal Failure) - Overview
Pipeline Products for Chronic Kidney Disease (Chronic Renal Failure) - Comparative Analysis
Chronic Kidney Disease (Chronic Renal Failure) - Therapeutics under Development by Companies
Chronic Kidney Disease (Chronic Renal Failure) - Therapeutics under Investigation by Universities/Institutes
Chronic Kidney Disease (Chronic Renal Failure) - Pipeline Products Glance
Late Stage Products
Clinical Stage Products
Early Stage Products
Chronic Kidney Disease (Chronic Renal Failure) - Products under Development by Companies
Chronic Kidney Disease (Chronic Renal Failure) - Products under Investigation by Universities/Institutes
Chronic Kidney Disease (Chronic Renal Failure) - Companies Involved in Therapeutics Development
Acceleron Pharma, Inc.
Angion Biomedica Corp.
Astellas Pharma Inc.
AstraZeneca Plc
Bayer AG
Bio-inRen
BioAegis Therapeutics, Inc.
Boehringer Ingelheim GmbH
Bristol-Myers Squibb Company
Cellmid Limited
Complexa, Inc.
CTI BioPharma Corp.
Evotec AG
F. Hoffmann-La Roche Ltd.
Gilead Sciences, Inc.
GNI Group Ltd.
Intercept Pharmaceuticals, Inc.
Lupin Limited
Navya Biologicals Pvt Ltd
Nippon Zoki Pharmaceutical Co., Ltd.
Novartis AG
Otsuka Holdings Co., Ltd.
Prismic Pharmaceuticals, Inc.
Prolong Pharmaceuticals, LLC
ProMetic Life Sciences Inc.
Reata Pharmaceuticals, Inc.
Red Glead Discovery AB
RegenMedTX, LLC
Resverlogix Corp.
Sphaera Pharma Pvt. Ltd.
Stelic Institute & Co., Inc.
Taisho Pharmaceutical Co., Ltd.
Thrasos Therapeutics Inc.
Toray Industries, Inc.
VBS Pharmaceuticals
Vicore Pharma AB
Chronic Kidney Disease (Chronic Renal Failure) - Therapeutics Assessment
Assessment by Monotherapy Products
Assessment by Combination Products
Assessment by Target
Assessment by Mechanism of Action
Assessment by Route of Administration
Assessment by Molecule Type
Drug Profiles
(palmidrol + silibinin) - Drug Profile
ambrisentan - Drug Profile
ANG-3070 - Drug Profile
ANG-3281 - Drug Profile
ANG-3586 - Drug Profile
apabetalone - Drug Profile
AS-2444697 - Drug Profile
bardoxolone methyl - Drug Profile
BI-655088 - Drug Profile
BLR-400 - Drug Profile
BMS-986177 - Drug Profile
BRN-1889 - Drug Profile
C-21 - Drug Profile
CAB-101 - Drug Profile
calcium succinate - Drug Profile
CAR Peptide - Drug Profile
cardiotoxin - Drug Profile
Cell Therapy for Chronic Kidney Disease and Metabolic Disorders - Drug Profile
CXA-10 - Drug Profile
dapagliflozin propanediol - Drug Profile
Drug for Kidney Diseases - Drug Profile
F-351 - Drug Profile
finerenone - Drug Profile
INT-767 - Drug Profile
KBP-5074 - Drug Profile
LHW-090 - Drug Profile
NAV-003 - Drug Profile
NZ-419 - Drug Profile
obinutuzumab - Drug Profile
pacritinib - Drug Profile
PBI-4050 - Drug Profile
PBI-4419 - Drug Profile
Recombinant Plasma Gelsolin Replacement for Renal Disease - Drug Profile
Recombinant Protein to Agonize ALK and BMP Receptors for Alport Syndrome, Kidney Diseases, Metabolic Disorders and Osteoarthritis - Drug Profile
Sanguinate - Drug Profile
Small Molecule to Agonize CaSR for Chronic Kidney Disease and Primary Hyperparathyroidism - Drug Profile
Small Molecule to Inhibit Sodium-Phosphate Cotransporter 2b for Chronic Kidney Disease and Hypertension - Drug Profile
Small Molecule to Inhibit Soluble Epoxide Hydrolase for Chronic Kidney Disease - Drug Profile
Small Molecules for Chronic Kidney Disease - Drug Profile
Small Molecules for Chronic Kidney Disease - Drug Profile
Small Molecules to Inhibit SphK2 for Autoimmune Disorders, Chronic Kidney Disease, Fibrosis, Neurodegenerative Diseases and Oncology - Drug Profile
sotatercept - Drug Profile
SP-20103 - Drug Profile
SPR-494 - Drug Profile
STNM-310 - Drug Profile
Synthetic Peptide to Modulate GHSR for Chronic Kidney Disease - Drug Profile
Synthetic Peptides for Chronic Kidney Disease - Drug Profile
TNT-009 - Drug Profile
tolvaptan - Drug Profile
torsemide ER - Drug Profile
TRC-101 - Drug Profile
TS-143 - Drug Profile
Vida-5 - Drug Profile
Chronic Kidney Disease (Chronic Renal Failure) - Dormant Projects
Chronic Kidney Disease (Chronic Renal Failure) - Discontinued Products
Chronic Kidney Disease (Chronic Renal Failure) - Product Development Milestones
Featured News & Press Releases
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer 193

LIST OF TABLES

Number of Products under Development for Chronic Kidney Disease (Chronic Renal Failure), H2 2016
Number of Products under Development for Chronic Kidney Disease (Chronic Renal Failure) - Comparative Analysis, H2 2016
Number of Products under Development by Companies, H2 2016
Number of Products under Development by Companies, H2 2016 (Contd..1)
Number of Products under Development by Companies, H2 2016 (Contd..2)
Number of Products under Investigation by Universities/Institutes, H2 2016
Comparative Analysis by Late Stage Development, H2 2016
Comparative Analysis by Clinical Stage Development, H2 2016
Comparative Analysis by Early Stage Development, H2 2016
Products under Development by Companies, H2 2016
Products under Development by Companies, H2 2016 (Contd..1)
Products under Development by Companies, H2 2016 (Contd..2)
Products under Investigation by Universities/Institutes, H2 2016
Chronic Kidney Disease (Chronic Renal Failure) - Pipeline by Acceleron Pharma, Inc., H2 2016
Chronic Kidney Disease (Chronic Renal Failure) - Pipeline by Angion Biomedica Corp., H2 2016
Chronic Kidney Disease (Chronic Renal Failure) - Pipeline by Astellas Pharma Inc., H2 2016
Chronic Kidney Disease (Chronic Renal Failure) - Pipeline by AstraZeneca Plc, H2 2016
Chronic Kidney Disease (Chronic Renal Failure) - Pipeline by Bayer AG, H2 2016
Chronic Kidney Disease (Chronic Renal Failure) - Pipeline by Bio-inRen, H2 2016
Chronic Kidney Disease (Chronic Renal Failure) - Pipeline by BioAegis Therapeutics, Inc., H2 2016
Chronic Kidney Disease (Chronic Renal Failure) - Pipeline by Boehringer Ingelheim GmbH, H2 2016
Chronic Kidney Disease (Chronic Renal Failure) - Pipeline by Bristol-Myers Squibb Company, H2 2016
Chronic Kidney Disease (Chronic Renal Failure) - Pipeline by Cellmid Limited, H2 2016
Chronic Kidney Disease (Chronic Renal Failure) - Pipeline by Complexa, Inc., H2 2016
Chronic Kidney Disease (Chronic Renal Failure) - Pipeline by CTI BioPharma Corp., H2 2016
Chronic Kidney Disease (Chronic Renal Failure) - Pipeline by Evotec AG, H2 2016
Chronic Kidney Disease (Chronic Renal Failure) - Pipeline by F. Hoffmann-La Roche Ltd., H2 2016
Chronic Kidney Disease (Chronic Renal Failure) - Pipeline by Gilead Sciences, Inc., H2 2016
Chronic Kidney Disease (Chronic Renal Failure) - Pipeline by GNI Group Ltd., H2 2016
Chronic Kidney Disease (Chronic Renal Failure) - Pipeline by Intercept Pharmaceuticals, Inc., H2 2016
Chronic Kidney Disease (Chronic Renal Failure) - Pipeline by Lupin Limited, H2 2016
Chronic Kidney Disease (Chronic Renal Failure) - Pipeline by Navya Biologicals Pvt Ltd, H2 2016
Chronic Kidney Disease (Chronic Renal Failure) - Pipeline by Nippon Zoki Pharmaceutical Co., Ltd., H2 2016
Chronic Kidney Disease (Chronic Renal Failure) - Pipeline by Novartis AG, H2 2016
Chronic Kidney Disease (Chronic Renal Failure) - Pipeline by Otsuka Holdings Co., Ltd., H2 2016
Chronic Kidney Disease (Chronic Renal Failure) - Pipeline by Prismic Pharmaceuticals, Inc., H2 2016
Chronic Kidney Disease (Chronic Renal Failure) - Pipeline by Prolong Pharmaceuticals, LLC, H2 2016
Chronic Kidney Disease (Chronic Renal Failure) - Pipeline by ProMetic Life Sciences Inc., H2 2016
Chronic Kidney Disease (Chronic Renal Failure) - Pipeline by Reata Pharmaceuticals, Inc., H2 2016
Chronic Kidney Disease (Chronic Renal Failure) - Pipeline by Red Glead Discovery AB, H2 2016
Chronic Kidney Disease (Chronic Renal Failure) - Pipeline by RegenMedTX, LLC, H2 2016
Chronic Kidney Disease (Chronic Renal Failure) - Pipeline by Resverlogix Corp., H2 2016
Chronic Kidney Disease (Chronic Renal Failure) - Pipeline by Sphaera Pharma Pvt. Ltd., H2 2016
Chronic Kidney Disease (Chronic Renal Failure) - Pipeline by Stelic Institute & Co., Inc., H2 2016
Chronic Kidney Disease (Chronic Renal Failure) - Pipeline by Taisho Pharmaceutical Co., Ltd., H2 2016
Chronic Kidney Disease (Chronic Renal Failure) - Pipeline by Thrasos Therapeutics Inc., H2 2016
Chronic Kidney Disease (Chronic Renal Failure) - Pipeline by Toray Industries, Inc., H2 2016
Chronic Kidney Disease (Chronic Renal Failure) - Pipeline by VBS Pharmaceuticals, H2 2016
Chronic Kidney Disease (Chronic Renal Failure) - Pipeline by Vicore Pharma AB, H2 2016
Assessment by Monotherapy Products, H2 2016
Assessment by Combination Products, H2 2016
Number of Products by Stage and Target, H2 2016
Number of Products by Stage and Mechanism of Action, H2 2016
Number of Products by Stage and Route of Administration, H2 2016
Number of Products by Stage and Molecule Type, H2 2016
Chronic Kidney Disease (Chronic Renal Failure) - Dormant Projects, H2 2016
Chronic Kidney Disease (Chronic Renal Failure) - Dormant Projects (Contd..1), H2 2016
Chronic Kidney Disease (Chronic Renal Failure) - Dormant Projects (Contd..2), H2 2016
Chronic Kidney Disease (Chronic Renal Failure) - Discontinued Products, H2 2016 185

LIST OF FIGURES

Number of Products under Development for Chronic Kidney Disease (Chronic Renal Failure), H2 2016
Number of Products under Development for Chronic Kidney Disease (Chronic Renal Failure) - Comparative Analysis, H2 2016
Number of Products under Development by Companies, H2 2016
Comparative Analysis by Late Stage Development, H2 2016
Comparative Analysis by Clinical Stage Development, H2 2016
Comparative Analysis by Early Stage Products, H2 2016
Assessment by Monotherapy Products, H2 2016
Number of Products by Top 10 Targets, H2 2016
Number of Products by Stage and Top 10 Targets, H2 2016
Number of Products by Top 10 Mechanism of Actions, H2 2016
Number of Products by Stage and Top 10 Mechanism of Actions, H2 2016
Number of Products by Routes of Administration, H2 2016
Number of Products by Stage and Routes of Administration, H2 2016
Number of Products by Molecule Types, H2 2016
Number of Products by Stage and Molecule Types, H2 2016
Skip to top


Ask Your Question

Chronic Kidney Disease (Chronic Renal Failure) - Pipeline Review, H2 2016
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: